Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Bullboard Posts
Post by superfido10on Jun 17, 2020 12:24pm
183 Views
Post# 31160656

Not Necessary to Respond to Amateur Shorts

Not Necessary to Respond to Amateur ShortsWho post lies and misinformation to protect their investment. Stupidly, they believe their moronic posts will shape the market and affect Share prices. The fact is that it was the FDA that recommended RVV go to level 3 testing after their meeting with RVV's top scientists who only requested to allow them to go to level 2. They recommended by this after reviewing the confirmed benefits and milestones achieved by the drug. Level 2 approval would have dramatically increased RVV's value. Level 3 approval will skyrocket our SP. It was the FDA that provided RVV with the exact guidance on what they need to submit in order to get approved unlike other Therapeutic companies that applied without encouragement from the FDA. There are as wellother amazing tools in the box for blue sky ahead. GLTA
Bullboard Posts